SLSN
SOLESENCE, INC.
-0.04 (-4.50%)0.84USD1.8K成交股數59.4M市值–本益比(近四季)1.1股價營收比-24.7%營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 15.3M-25% | 13.0M-11% | 12.5M-26% | 14.6M+12% | 20.4M+106% | 14.6M+83% | 16.9M+112% | 13.0M+10% | 9.9M | 8.0M | 8.0M | 11.9M |
| 營業成本 | 10.6M | 9.8M | 9.6M | 11.2M | 13.9M | 11.2M | 10.8M | 9.3M | 6.3M | 7.5M | 6.4M | 8.2M |
| 毛利 | 4.7M-26% | 3.1M-7% | 2.9M-53% | 3.4M-10% | 6.4M+80% | 3.4M+618% | 6.1M+299% | 3.7M+2% | 3.6M | 471K | 1.5M | 3.7M |
| 毛利率 | 31.0% | 24.2% | 23.0% | 23.1% | 31.6% | 23.1% | 36.2% | 28.7% | 36.3% | 5.9% | 19.2% | 31.0% |
| 研發費用 | 947K | 1.0M | 1.0M | 1.1M | 955K | 1.0M | 970K | 864K | 910K | 786K | 1.1M | 991K |
| 銷售管理費用 | 3.7M | 2.8M | 2.2M | 3.1M | 3.0M | 2.1M | 1.9M | 1.8M | 1.6M | 1.6M | 1.7M | 2.1M |
| 營業利益 | 121K-95% | −700K-373% | −379K-112% | −781K-175% | 2.5M+123% | 256K-113% | 3.2M-362% | 1.0M+81% | 1.1M | −1.9M | −1.2M | 579K |
| 營業利益率 | 0.8% | -5.4% | -3.0% | -5.4% | 12.2% | 1.8% | 19.0% | 8.0% | 11.3% | -23.7% | -15.4% | 4.9% |
| 稅後淨利 | −158K-105% | −962K-380% | −666K-122% | −1.1M-231% | 3.2M+262% | 343K-116% | 3.0M-312% | 856K+157% | 893K | −2.1M | −1.4M | 333K |
| 淨利率 | -1.0% | -7.4% | -5.3% | -7.7% | 15.9% | 2.3% | 18.1% | 6.6% | 9.0% | -26.6% | -18.0% | 2.8% |
| 稀釋 EPS | 0.00-100% | -0.01 | 0.00-100% | -0.02-300% | 0.04+100% | 0.00-100% | 0.04-233% | 0.010% | 0.02 | -0.05 | -0.03 | 0.01 |
| 稀釋股數 | 70.6M | 70.6M | 72.6M | 70.5M | 72.6M | 72.6M | 71.9M | 58.7M | 58.0M | 49.6M | 49.6M | 50.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.0M | 573K | 1.3M | 429K | 4.1M | 1.8M | 2.9M | 2.4M | 2.0M | 1.7M | 1.2M | 2.2M |
| 應收帳款 | 9.3M | 6.4M | 6.8M | 9.7M | 11.0M | 9.1M | 8.7M | 5.9M | 5.2M | 3.5M | 3.2M | 5.7M |
| 存貨 | 13.0M | 13.8M | 15.0M | 18.9M | 19.8M | 21.9M | 15.0M | 13.9M | 13.3M | 10.0M | 10.1M | 8.4M |
| 總資產 | 46.4M | 44.1M | 46.5M | 54.0M | 60.0M | 57.0M | 48.0M | 40.8M | 38.5M | 32.9M | 32.3M | 34.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | 1.0M | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 13.2M | 13.2M | 14.1M | 17.2M | 14.4M | 10.8M | 15.2M | 11.9M | 5.0M | 1.9M | 3.9M | 5.2M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | 188K | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.5M-121% | – | – | – | −7.2M | – | – | −3.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 85K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −3.9M | – | – | – |
| 折舊攤銷 | – | 313K | – | – | – | 226K | – | – | 234K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -39.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 62.3M
| Consumer Products | 54.9M | 88.0% | +23.7% |
|---|---|---|---|
| Personal Care Ingredients | 6.3M | 10.2% | -7.1% |
| Advanced Materials | 857K | 1.4% | -25.3% |
| Product And Service Other | 270K | 0.4% | -40.9% |
| 產品 小計 | 61.8M | 99.1% | +19.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 62.1M | +18.6% | 1.8M | 2.9% | 0.02 | – |
| FY2024 | 52.3M | +40.4% | 4.2M | 8.1% | 0.07 | −2.6M |
| FY2023 | 37.3M | -0.1% | −4.4M | -11.8% | -0.09 | −3.1M |
| FY2022 | 37.3M | +26.6% | −2.6M | -7.0% | -0.05 | −4.5M |
| FY2021 | 29.5M | +72.1% | 2.3M | 7.9% | 0.05 | 447K |
| FY2020 | 17.1M | +36.9% | 989K | 5.8% | 0.03 | −2.9M |
| FY2019 | 12.5M | -11.9% | −3.0M | -24.0% | -0.08 | −3.5M |
| FY2018 | 14.2M | – | −2.1M | -14.7% | -0.06 | −1.5M |